The FDA has approved a first-of-its-kind wearable electrical device — Optune Pax (Novocure) — for patients with locally ...

First approved therapy for locally advanced disease in almost three decades ...

The Swiss biopharmaceutical company’s shares surged in after-hours trading after it said the FDA approved its Optune Pax ...

Even before a tumor in the pancreas becomes discernible, an activated cancer gene actively remodels its future environment ...

Your pancreas has important jobs to do. A large gland behind the lower part of the stomach, it produces hormones that ...

Pancreatic cancer is one of the most lethal forms of cancer, and it’s crucial to understand why. Learn about the challenges in diagnosing and treating this aggressive disease, and why early detection ...

An experimental drug combination was able to effectively treat pancreatic cancer in mouse models without tumor resistance.

The FDA has approved a new tumor treating fields (TTF) therapy, Optune Pax, for the treatment of adult patients with locally ...

A first-of-its-kind device for pancreatic cancer treatment has been approved by the U.S. Food and Drug Administration.

In a lab-grown cell study focused on potential new treatment targets for halting the spread of most pancreatic cancers, Johns ...

With this decision, Optune Pax becomes the first new FDA-approved treatment for locally advanced pancreatic cancer in decades. For patients and families navigating this diagnosis, the addition of a ...

On this Valentine's Day, a couple recalls everything they had to overcome from long distance to three cancer diagnoses over ...